Coeptis Therapeutics Statistics
Total Valuation
COEP has a market cap or net worth of $12.18 million. The enterprise value is $8.23 million.
| Market Cap | 12.18M |
| Enterprise Value | 8.23M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
COEP has 34.11 million shares outstanding. The number of shares has increased by 79.70% in one year.
| Shares Outstanding | 34.11M |
| Shares Change (YoY) | +79.70% |
| Shares Change (QoQ) | -3.60% |
| Owned by Insiders (%) | 32.54% |
| Owned by Institutions (%) | 13.14% |
| Float | 20.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.78 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.76 |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -196.49 |
Financial Efficiency
Return on equity (ROE) is -738.80% and return on invested capital (ROIC) is -388.05%.
| Return on Equity (ROE) | -738.80% |
| Return on Assets (ROA) | -300.20% |
| Return on Capital (ROIC) | -388.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.25M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.35% in the last 52 weeks. The beta is -0.89, so COEP's price volatility has been lower than the market average.
| Beta (1Y) | -0.89 |
| 52-Week Price Change | -77.35% |
| 50-Day Moving Average | 0.41 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 44.12 |
| Average Volume (30 Days) | 263,372 |
Short Selling Information
The latest short interest is 107,648, so 0.32% of the outstanding shares have been sold short.
| Short Interest | 107,648 |
| Short Previous Month | 39,720 |
| Short % of Shares Out | 0.32% |
| Short % of Float | 0.53% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.49M |
| Pretax Income | -21.27M |
| Net Income | -21.27M |
| EBITDA | -20.16M |
| EBIT | -21.16M |
| Earnings Per Share (EPS) | -$0.83 |
Balance Sheet
The company has $4.97 million in cash and $1.22 million in debt, giving a net cash position of $3.74 million or $0.11 per share.
| Cash & Cash Equivalents | 4.97M |
| Total Debt | 1.22M |
| Net Cash | 3.74M |
| Net Cash Per Share | $0.11 |
| Equity / Book Value | 4.31M |
| Book Value Per Share | 0.13 |
| Working Capital | 2.26M |
Cash Flow
| Operating Cash Flow | -7.24M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.24M |
| FCF Per Share | -$0.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COEP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -79.70% |
| Shareholder Yield | -79.70% |
| Earnings Yield | -177.64% |
| FCF Yield | -60.47% |
Analyst Forecast
The average price target for COEP is $6.50, which is 1,756.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 1,756.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -2.40% |
Stock Splits
The last stock split was on August 6, 2020. It was a reverse split with a ratio of 1:40000.
| Last Split Date | Aug 6, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:40000 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |